TREATMENT FOR RECURRENT GLIOBLASTOMA: ARE THERE SUCCESSES?

G. I. Kobyakov; Кобяков Г. Л.; A. V. Smolin; Смолин А. В.; A. Kh. Bekyashev; Бекяшев А. Х.; O. V. Absalyamova; Абсалямова О. В.; E. A. Kobyakova; Кобякова Е. А.; A. A. Poddubsky; Поддубский А. А.; M. V. Inozemtseva; Иноземцева М. В.

doi:10.17650/2222-1468-2014-0-3-872-878

TREATMENT FOR RECURRENT GLIOBLASTOMA: ARE THERE SUCCESSES?

Authors: Kobyakov G.I.¹, Smolin A.V.², Bekyashev A.K.³, Absalyamova O.V.¹, Kobyakova E.A.³, Poddubsky A.A.¹, Inozemtseva M.V.¹
Affiliations:
1. Acad. N.N. Burdenko Neurosurgery Research Institute, Moscow
2. Acad. N.N. Burdenko Main Military Clinical Hospital, Ministry of Defense of Russia
3. N.N. Blokhin Russian Cancer Research Center, Moscow
Issue: Vol 4, No 3 (2014)
Pages: 12-21
Section: DIAGNOSIS AND TREATMENT OF HEAD AND NECK TUMORS
Published: 15.04.2014
URL: https://ogsh.abvpress.ru/jour/article/view/85
DOI: https://doi.org/10.17650/2222-1468-2014-0-3-872-878
ID: 85

Cite item

Full Text

Abstract
About the authors
References
Supplementary files
Statistics

Abstract

The paper analyzes treatments for glioblastoma. The role of resurgery, reradiotherapy, and antitumor drug therapy in the treatment of recurrent glioblastoma has been studied. Multicenter trials of the use of temozolamide and temozolomide in combination with bevacizumab have been reviewed. It has been shown that the use of bevacizumab to treat patients with glioblastoma makes it possible to increase survival and to improve quality of life.